CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-75.81M | +12.4% |
| 2024 | $-86.54M | -52.2% |
| 2023 | $-56.88M | +49.5% |
| 2022 | $-112.53M | +6.7% |
| 2021 | $-120.64M | -4189.5% |
| 2020 | $2.95M | +102.0% |
| 2019 | $-143.98M | -81.5% |
| 2018 | $-79.31M | -147.0% |
| 2017 | $168.81M | +4111.7% |
| 2016 | $-4.21M | - |